Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure

American Journal of Medicine

Volumn 103, Issue 3, 1997, Pages 197-207

  Shane, Elizabeth ^a   Mancini, Donna ^a   Aaronson, Keith ^a   Silverberg, Shonni J ^a   Seibel, Markus J ^b   Addesso, Vicki ^a   McMahon, Donald J ^a  

^a Coll Phys Surgs Columbia Univ ^*  (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE MASS; BONE MINERAL; BONE TURNOVER; CARDIOVASCULAR FUNCTION; CONGESTIVE HEART FAILURE; CROSS LINKING; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEART TRANSPLANTATION; HOMEOSTASIS; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; VITAMIN D DEFICIENCY;

ADULT; AGED; BONE DENSITY; BONE REGENERATION; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; OSTEOPOROSIS; SEVERITY OF ILLNESS INDEX; VITAMIN D DEFICIENCY;

EID: 0030852304     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00142-3     Document Type: Article

References (48)

1. Braunwald E. Heart failure. Wilson JD, Braunwald E, Isselbacher KJ, et al. Principles of Internal Medicine. 13 ed. 1994;998-1009 McGraw-Hill, Inc, New York.
2. Muchmore JS, Cooper DKC, Ye Y, et al. Loss of vertebral bone density in heart transplant patients. Transplant Proc. 23:1991;1184-1185.
3. Lee AH, Mull RL, Keenan GF, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med. 96:1994;35-41.
4. Van Cleemput J, Daenen W, Nijs J, et al. Timing and quantification of bone loss in cardiac transplant recipients. Transplant Int. 8:1995;196-200.
5. Shane E, Rivas M, McMahon DJ, et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab. In press. 1996.
6. Shane E, Rivas M, Staron RB, et al. Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab. 81:1996;1740-1746.
7. Mok LL, Nichols GA, Thompson JC, Cooper CW. Parathyroid hormone as a smooth muscle relaxant. Endocrinol Rev. 10:1989;420-436.
8. Thiede MA, Nickols GA. Local expression and action of parathyroid hormone-related protein in the cardiovascular system. Crass MF III, Avoid LV. Calcium-Regulating Hormones and Cardiovascular Function. 1995;131-173 CRC Press, Boca Raton.
9. Dipette DJ, Christenson W, Nickols MA, Nickols GA. Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology. 130:1992;2045-2051.
10. Ogino K, Burkhoff D, Bilezikian JP. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology. 136:1995;3024-3030.
11. Hara M, Liu YM, Cohen IS, et al. Parathyroid hormone and related peptide modulate impulse initiation and pacemaker current in the heart. Circulation. 92:8:1995;1-639.
12. Walters M. Newly identified actions of the vitamin D endocrine system. Endocrine Rev. 13:1992;719-763.
13. 3. Crass MF III, Avioli LV. Calcium-Regulating Hormones and Cardiovascular Function. 1995;175-190 CRC Press, Boca Raton.
14. 3 and cardiac muscle and function. Crass MF III, Avioli LV. Calcium-Regulating Hormones and Cardiovascular Function. 1995;191-211 CRC Press, Boca Raton.
15. Hochhauser E, Barak J, Kushnir T, et al. Mechanical, biochemical, and structural effects of vitamin D deficiency on the chick heart. Angiology. 1:1989;300-308.
16. 3 with cardiovascular function. II. Direct and indirect effects. Am J Physiol. 253:1987;E675-E683.
17. 3 and cardiovascular function in rats. J Clin Invest. 79:1987;1706-1802.
18. 3 administration. J Hypertens. 10:1992;939-947.
19. 2D on cardiovascular function. Contrib Nephrol. 90:1991;79-87.
20. Scragg R, Jackson R, Holdaway IM, et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D levels: a community-based study. Int J Epidemiol. 19:1990;559-563.
21. Scragg R. Sunlight, vitamin D and cardiovascular disease. Crass MF III, Avioli LV. Calcium-Regulating Hormones and Cardiovascular Function. 1995;213-237 CRC Press, Boca Raton.
22. Levine SN, Rheams CN. Hypocalcemic heart failure. Am J Med. 78:1985;1033-1035.
23. Huddle KR. Cardiac dysfunction in primary hypoparathyroidism. South Afr Med J. 73:1988;242-244.
24. Brunvand L, Haga P, Tangsrud SE, Haug E. Congestive heart failure caused by vitamin D deficiency? Acta Paediatr. 84:1995;106-108.
25. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786.
26. Shane E. Hypercalcemia: pathogenesis, clinical manifestations, and differential diagnosis. Favus MJ. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd Ed. 1996;177-181 Lippincott-Raven, Philadelphia.
27. Delmas PD, Malaval L, Arlot M, Meunier PJ. Serum bone gla-protein compared to bone histomorphometry in endocrine disease. Bone. 6:1985;329-341.
28. Gundberg CM, Wilson PS, Gallop PM, Parfitt AM. Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay. Clin Chem. 31:1985;1720-1723.
29. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 33:1987;1364-1367.
30. Preece MA, O'Riordan JLH, Lawson DEM, Kodicek E. An assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum. Clin Chim Acta. 54:1974;235-242.
31. Reinhardt TA, Horst RL, Orf JW, Hollis BW. A microassay for 1,25-dihydroxyvitamin D not requiring high-performance liquid chromotography: application to clinical studies. J Clin Endocrinol Metab. 58:1984;91-98.
32. Kivirikko KI, Laitenen O, Prockop DJ. Modification of a specific assay for hydroxyproline in urine. Anal Biochem. 19:1967;249-255.
33. Seibel MJ, Robins SP, Bilezikian JP. Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab. 3:1992;263-270.
34. Black D, Duncan A, Robins SP. Quantitative analysis of pyridinium cross-links of collagen in urine using ion-paired reversed-phase high performance liquid chromatography. Anal Biochem. 137:1989;380-388.
35. Kanis JA, Melton LJ, Christiansen C, et al. Perspective. The diagnosis of osteoporosis. J Bone Miner Res. 9:1994;1137-1141.
36. Genant HK, Grampp S, Gluer CC, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res. 9:1994;1503-1514.
37. Looker AC, Wahner HW, Dunn WL, et al. Proximal femur bone mineral levels of US adults. Osteoporosis Int. 5:1995;85-409.
38. Faulkner KG, McClung MR. Standardization of femoral neck T scores from Hologic and Lunar DPX systems. Osteoporosis Int. 6:(Suppl 1):1996;S133.
39. Shane E, Silverberg SJ, Donovan D, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med. 101:1996;262-269.
40. Epstein S, Shane E. Transplantation osteoporosis. Marcus R, Feldman D, Kelsey J. Osteoporosis. 1996;947-957 Academic Press, New York.
41. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med. 320:1989;980-991.
42. Cannon PJ. The kidney in heart failure. N Engl J Med. 296:1977;26-32.
43. Packer M, Lee WH, Kessler PD. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation. 74:1986;766-774.
44. Braunwald E. Normal and abnormal myocardial function. Wilson JD, Braunwald E, Isselbacher KJ, et al. Principles of Internal Medicine. 13 ed. 1994;989-998 McGraw-Hill, Inc, New York.
45. Jaloga GP, Chernow B. Hypocalcemia in critical illness. JAMA. 256:1986;1924-1929.
46. Connor TB, Rosen BL, Blaustein MP, et al. Hypocalcemia precipitating congestive heart failure. N Engl J Med. 307:1982;869-872.
47. Moseley JM, Danks JA, Grill V, et al. Immunohistochemical detection of parathyroid hormone-related protein in fetal tissues. J Clin Endocrinol Metab. 73:1991;478-484.
48. in vitro. Endocrinology. 134:1994;2230-2236.